Algiax Pharmaceuticals logo

Algiax Pharmaceuticals

Disarming chronic neuropathic pain

5 employees · est. 2011 · Erkrath, Germany

VS
Phenomix logo

Phenomix

A pioneering biotech company dedicated to developing groundbreaking therapies for diabetes and hepatitis C.

est. 2001

Phenomix is the older company (2011 vs 2001).

Side-by-Side Comparison

Algiax Pharmaceuticals Phenomix
Founded
2011 2001 older
Headquarters
Erkrath, Germany Not tracked yet
Employees
5 Not tracked yet
Industry
Biotechnology, Health Care, Pharmaceutical Biotechnology, Health Care, Pharmaceutical
Funding Stage
Unknown Series Unknown
Total Funding
$4.30M $106.56M
Funding Rounds
2 6
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Algiax Pharmaceuticals GmbH, Biotechnology Company, Neuropathic Pain, Acute Spinal Cord Injury, Drug Development, Clinical Development, Pharmaceutical Industry, Series A Financing, Innovation, Diabetes Type 1, Preclinical Development, Venture Capital, Neurological Disorders, Medical Research, Clinical Trials Biotech Company, Drug Discovery, Therapeutics, Type 2 Diabetes, DPP4 Inhibitor, Hepatitis C, NS3/4A Viral Protease, Clinical Trials, San Diego, Pharmaceutical Research, Innovative Therapies, Clinical Candidate, Forest Laboratories, Financial Partnership, Company Closure
Website
algiax.com phenomixcorp.com
Algiax Pharmaceuticals logo

About Algiax Pharmaceuticals

Algiax Pharmaceuticals is an independent biotechnology company founded in 2011 and based in Germany. The company is dedicated to disarming chronic neuropathic pain, with a strong focus on neuropathic pain and acute spinal cord injury within the nervous system disease field. Their lead candidate AP-3...

Phenomix logo

About Phenomix

Phenomix was a pioneering biotech company with a focus on developing groundbreaking therapies for diabetes and hepatitis C. Founded in 2001 and headquartered in San Diego, the firm aimed to address significant human diseases through innovative therapeutics. Their lead clinical candidate, PHX1149, a...

We will tell you when either one moves

BounceWatch watches Algiax Pharmaceuticals and Phenomix for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Algiax Pharmaceuticals and Phenomix — by email.

Frequently Asked Questions

Algiax Pharmaceuticals — Disarming chronic neuropathic pain. Phenomix — A pioneering biotech company dedicated to developing groundbreaking therapies for diabetes and hepatitis C.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Algiax Pharmaceuticals has raised $4.30M while Phenomix has raised $106.56M.
Algiax Pharmaceuticals and Phenomix operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Algiax Pharmaceuticals with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Algiax Pharmaceuticals on 28 May 2026, and Phenomix on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy